Literature DB >> 7495749

Human naive T cells activated by cytokines differentiate into a split phenotype with functional features intermediate between naive and memory T cells.

D Unutmaz1, F Baldoni, S Abrignani.   

Abstract

We have recently shown that CD45RA+CD4+ naive T cells can be activated to proliferate by a combination of IL-2, TNF-alpha and IL-6, but, at variance with TCR-mediated activation, they do not acquire the CD45RO molecule. This prompted us to investigate the phenotype of these cells and the functional features they display upon TCR stimulation. Naive T cells expanded by cytokines, though remaining CD45RA+, express a variety of activation and adhesion molecules which are peculiar to effector or memory T cells. Naive cells primed by cytokines, when activated with anti-CD3 mAb, produce a broad spectrum of cytokines, express CD40 ligand, but are unable to help B cells for Ig synthesis. A subset of CD4+CD45RA+RO-T cells with a phenotype (HLA-DR-, VLA-2+ or IL-2R+) similar to that of cells activated by cytokines in vitro can be found in vivo. These results demonstrate that activation signals delivered by cytokines, in the absence of TCR stimulation, can activate naive T cells to proliferate and differentiate into a 'split phenotype' with elements common to both naive and memory T cells. This novel antigen-independent activation may help to maintain the naive T cell repertoire and facilitate the antigen-responsiveness of naive T cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7495749     DOI: 10.1093/intimm/7.9.1417

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  19 in total

1.  Proliferative responses of blood mononuclear cells (BMNC) in a cohort of elderly humans: role of lymphocyte phenotype and cytokine production.

Authors:  H Bruunsgaard; A N Pedersen; M Schroll; P Skinhøj; B K Pedersen
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

2.  Persistence and emergence of X4 virus in HIV infection.

Authors:  Ariel D Weinberger; Alan S Perelson
Journal:  Math Biosci Eng       Date:  2011-04       Impact factor: 2.080

3.  T cell signaling mechanisms that regulate HIV-1 infection.

Authors:  D Unutmaz
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

4.  Impact of immune plasticity on development of cellular memory responses to human immunodeficiency virus type 1.

Authors:  Michael A Kolber
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

5.  In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients.

Authors:  Irini Sereti; Hiromi Imamichi; Ven Natarajan; Tomozumi Imamichi; Meena S Ramchandani; Yunden Badralmaa; Steve C Berg; Julia A Metcalf; Barbara K Hahn; Jean M Shen; April Powers; Richard T Davey; Joseph A Kovacs; Ethan M Shevach; H Clifford Lane
Journal:  J Clin Invest       Date:  2005-06-02       Impact factor: 14.808

Review 6.  Immune responses throughout hepatitis C virus (HCV) infection: HCV from the immune system point of view.

Authors:  S Abrignani
Journal:  Springer Semin Immunopathol       Date:  1997

7.  Putative role for interleukin-7 in the maintenance of the recirculating naive CD4+ T-cell pool.

Authors:  L M Webb; B M Foxwell; M Feldmann
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

8.  Naïve T-cell dynamics in human immunodeficiency virus type 1 infection: effects of highly active antiretroviral therapy provide insights into the mechanisms of naive T-cell depletion.

Authors:  Michele Di Mascio; Irini Sereti; Lynn T Matthews; Ven Natarajan; Joseph Adelsberger; Richard Lempicki; Christian Yoder; Elizabeth Jones; Catherine Chow; Julia A Metcalf; Igor A Sidorov; Dimiter S Dimitrov; Michael A Polis; Joseph A Kovacs
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

9.  Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype.

Authors:  Deirdre D Scripture-Adams; David G Brooks; Yael D Korin; Jerome A Zack
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

10.  Accelerated immunodeficiency by anti-CCR5 treatment in HIV infection.

Authors:  Ariel D Weinberger; Alan S Perelson; Ruy M Ribeiro; Leor S Weinberger
Journal:  PLoS Comput Biol       Date:  2009-08-14       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.